Replimune Group, Inc.

REPL

$15.23

-0.39%

2026-09-04 09:40:26 EDT-$0.06

Healthcare

Biotechnology

NASDAQ

Active Trading

Replimune Group, Inc. is a biotechnology enterprise dedicated to pioneering oncolytic immuno-gene therapies aimed at treating various cancers. The company leverages its ...

Historical Employee Count of REPL

Current

465

Change

-2.92%

Minimum

206

Maximum

479

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Mar 31, 2026	465	10-K	Jun 29, 2026	View
Mar 31, 2025	479	10-K	May 22, 2025	View
Mar 31, 2024	331	10-K	May 16, 2024	View
Mar 31, 2023	284	10-K	May 18, 2023	View
Mar 31, 2022	206	10-K	May 19, 2022	View

Supply Chain of REPL

Upstream / Downstream / Proxies

Upstream

Bristol-Myers Squibb CompanyNYSE:BMY Incyte CorporationNASDAQ:INCYRoche Holding AG / GenentechSWX:ROGRegeneron PharmaceuticalsNASDAQ:REGN Thermo Fisher ScientificNYSE:TMO VWR International (Avantor)NYSE:AVTRCell Culture Media & Reagent SuppliersContract Manufacturing Organizations (CDMOs)Gibco (Thermo Fisher)Corning Life SciencesBio-Techne CorporationNASDAQ:TECH

Downstream

FDA - U.S. Food and Drug AdministrationOncology Clinical Research Sites (Global)Specialty Pharmacies (post-approval)Bristol-Myers Squibb CompanyNYSE:BMY Incyte CorporationNASDAQ:INCYRoche/GenentechSWX:ROG

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer